• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中的脑线粒体功能障碍和氧化损伤。

Brain mitochondrial dysfunction and oxidative damage in Parkinson's disease.

机构信息

Department of Biochemistry and Molecular Biology, School of Medicine, University of Cádiz, Plaza Fragela, 9, 11003, Cádiz, Spain.

出版信息

J Bioenerg Biomembr. 2009 Dec;41(6):517-21. doi: 10.1007/s10863-009-9250-6.

DOI:10.1007/s10863-009-9250-6
PMID:19915964
Abstract

Complex factors contribute to the appearance of Parkinson's disease (PD), but with a constant mitochondrial involvement. There are two interdependent conditions in PD: brain mitochondrial dysfunction and brain mitochondrial oxidative damage. Mitochondrial dysfunction and reduced complex I activity are recognized in substantia nigra and in frontal cortex in PD patients. The molecular mechanism involved in the inactivation of complex I is likely accounted by the sum of ONOO(-) mediated reactions, reactions with free radical intermediates of the lipid peroxidation process and amine-aldehyde adduction reactions. The inhibitory effects on complex I lead synergistically to denaturation of the protein structure and to further increases of O(2)(-) and ONOO(-) production at the vicinity of complex I. An adaptive response in PD patients has been described with increases in mtNOS activity, mitochondrial mass and mitochondrial biogenesis. Mitochondrial dysfunction in the human frontal cortex is to be considered a factor contributing to impaired cognition in PD.

摘要

复杂的因素导致帕金森病(PD)的出现,但始终与线粒体有关。PD 有两种相互依存的情况:大脑线粒体功能障碍和大脑线粒体氧化损伤。PD 患者的黑质和额叶皮层中存在线粒体功能障碍和复合物 I 活性降低。复合物 I 失活所涉及的分子机制可能归因于 ONOO(-)介导的反应、脂质过氧化过程中自由基中间体的反应以及胺-醛加成反应的总和。对复合物 I 的抑制作用协同导致蛋白质结构变性,并在复合物 I 附近进一步增加 O(2)(-)和 ONOO(-)的产生。PD 患者的适应性反应表现为 mtNOS 活性、线粒体质量和线粒体生物发生增加。人类额叶皮层的线粒体功能障碍被认为是 PD 认知障碍的一个因素。

相似文献

1
Brain mitochondrial dysfunction and oxidative damage in Parkinson's disease.帕金森病中的脑线粒体功能障碍和氧化损伤。
J Bioenerg Biomembr. 2009 Dec;41(6):517-21. doi: 10.1007/s10863-009-9250-6.
2
Human brain cortex: mitochondrial oxidative damage and adaptive response in Parkinson disease and in dementia with Lewy bodies.人类大脑皮层:帕金森病和路易体痴呆中的线粒体氧化损伤及适应性反应。
Free Radic Biol Med. 2009 Jun 15;46(12):1574-80. doi: 10.1016/j.freeradbiomed.2009.03.007. Epub 2009 Mar 17.
3
Brain mitochondrial dysfunction in aging, neurodegeneration, and Parkinson's disease.衰老、神经退行性变和帕金森病中的脑线粒体功能障碍。
Front Aging Neurosci. 2010 Sep 1;2. doi: 10.3389/fnagi.2010.00034. eCollection 2010.
4
Oxidative stress in Parkinson's disease.帕金森病中的氧化应激
Ann Neurol. 2003;53 Suppl 3:S26-36; discussion S36-8. doi: 10.1002/ana.10483.
5
Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage.帕金森病大脑中存在神经元复合物 I 缺陷,但与神经退行性变或线粒体 DNA 损伤无关。
Acta Neuropathol. 2018 Mar;135(3):409-425. doi: 10.1007/s00401-017-1794-7. Epub 2017 Dec 21.
6
Mitochondria, oxidative damage, and inflammation in Parkinson's disease.帕金森病中的线粒体、氧化损伤与炎症
Ann N Y Acad Sci. 2003 Jun;991:120-31. doi: 10.1111/j.1749-6632.2003.tb07470.x.
7
The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease.多巴胺氧化在线粒体功能障碍中的作用:对帕金森病的影响。
J Bioenerg Biomembr. 2009 Dec;41(6):469-72. doi: 10.1007/s10863-009-9257-z.
8
Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease.泛醌(辅酶Q10)与帕金森病氧化应激中的线粒体
Biol Signals Recept. 2001 May-Aug;10(3-4):224-53. doi: 10.1159/000046889.
9
Complex I syndrome in striatum and frontal cortex in a rat model of Parkinson disease.帕金森病大鼠模型纹状体和额叶皮质中的复合物 I 综合征。
Free Radic Biol Med. 2019 May 1;135:274-282. doi: 10.1016/j.freeradbiomed.2019.03.001. Epub 2019 Mar 9.
10
Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.帕金森病发病机制中的线粒体功能障碍成为焦点。
Biochim Biophys Acta. 2009 Jul;1792(7):651-63. doi: 10.1016/j.bbadis.2008.11.007. Epub 2008 Nov 14.

引用本文的文献

1
Targeting the NRF2 pathway for disease modification in neurodegenerative diseases: mechanisms and therapeutic implications.针对NRF2通路进行神经退行性疾病的疾病修饰:机制与治疗意义
Front Pharmacol. 2024 Jul 25;15:1437939. doi: 10.3389/fphar.2024.1437939. eCollection 2024.
2
Restoring Mitochondrial Function and Muscle Satellite Cell Signaling: Remedies against Age-Related Sarcopenia.恢复线粒体功能和肌肉卫星细胞信号传导:对抗与年龄相关的肌肉减少症的疗法。
Biomolecules. 2024 Mar 28;14(4):415. doi: 10.3390/biom14040415.
3
Anti oxidative/neuro-inflammation properties of on rotenone induced stress in rat brain.

本文引用的文献

1
Elevated neuronal nitric oxide synthase expression during ageing and mitochondrial energy production.衰老过程中神经元型一氧化氮合酶表达升高与线粒体能量产生
Free Radic Res. 2009 May;43(5):431-9. doi: 10.1080/10715760902849813.
2
Human brain cortex: mitochondrial oxidative damage and adaptive response in Parkinson disease and in dementia with Lewy bodies.人类大脑皮层:帕金森病和路易体痴呆中的线粒体氧化损伤及适应性反应。
Free Radic Biol Med. 2009 Jun 15;46(12):1574-80. doi: 10.1016/j.freeradbiomed.2009.03.007. Epub 2009 Mar 17.
3
Protein tyrosine nitration--an update.
[物质名称]对鱼藤酮诱导的大鼠脑应激的抗氧化/神经炎症特性
Bioinformation. 2023 Jun 30;19(6):729-738. doi: 10.6026/97320630019729. eCollection 2023.
4
Interactions between gut microbiota and Parkinson's disease: The role of microbiota-derived amino acid metabolism.肠道微生物群与帕金森病之间的相互作用:微生物群衍生的氨基酸代谢的作用。
Front Aging Neurosci. 2022 Nov 2;14:976316. doi: 10.3389/fnagi.2022.976316. eCollection 2022.
5
Physical Exercise as a Modulator of Vascular Pathology and Thrombin Generation to Improve Outcomes After Traumatic Brain Injury.运动锻炼作为一种调节血管病理学和凝血酶生成的手段,可改善创伤性脑损伤后的转归。
Mol Neurobiol. 2022 Feb;59(2):1124-1138. doi: 10.1007/s12035-021-02639-9. Epub 2021 Nov 30.
6
Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer's Disease.Nrf2信号通路在帕金森病和阿尔茨海默病氧化损伤及线粒体功能障碍中的作用
Antioxidants (Basel). 2021 Jul 2;10(7):1069. doi: 10.3390/antiox10071069.
7
Peroxynitrite decomposition catalyst enhances respiratory function in isolated brain mitochondria.过氧亚硝酸盐分解催化剂增强离体脑线粒体的呼吸功能。
Am J Physiol Heart Circ Physiol. 2021 Feb 1;320(2):H630-H641. doi: 10.1152/ajpheart.00389.2020. Epub 2020 Nov 8.
8
Nutraceuticals in Neurological Disorders.神经疾病中的营养保健品。
Int J Mol Sci. 2020 Jun 22;21(12):4424. doi: 10.3390/ijms21124424.
9
NRF2 as a Therapeutic Target in Neurodegenerative Diseases.NRF2 作为神经退行性疾病的治疗靶点。
ASN Neuro. 2020 Jan-Dec;12:1759091419899782. doi: 10.1177/1759091419899782.
10
Making sense of gut feelings in the traumatic brain injury pathogenesis.解读创伤性脑损伤发病机制中的直觉反应。
Neurosci Biobehav Rev. 2019 Jul;102:345-361. doi: 10.1016/j.neubiorev.2019.05.012. Epub 2019 May 16.
蛋白质酪氨酸硝化作用——最新进展
Arch Biochem Biophys. 2009 Apr 15;484(2):117-21. doi: 10.1016/j.abb.2008.10.034. Epub 2008 Oct 30.
4
Mitochondrial nitric oxide synthase, mitochondrial brain dysfunction in aging, and mitochondria-targeted antioxidants.线粒体一氧化氮合酶、衰老过程中的线粒体脑功能障碍以及线粒体靶向抗氧化剂。
Adv Drug Deliv Rev. 2008 Oct-Nov;60(13-14):1534-44. doi: 10.1016/j.addr.2008.05.002. Epub 2008 Jul 4.
5
Brain mitochondrial dysfunction in aging.衰老过程中的脑线粒体功能障碍。
IUBMB Life. 2008 May;60(5):308-14. doi: 10.1002/iub.46.
6
Mitochondria in the aetiology and pathogenesis of Parkinson's disease.线粒体在帕金森病的病因学和发病机制中的作用
Lancet Neurol. 2008 Jan;7(1):97-109. doi: 10.1016/S1474-4422(07)70327-7.
7
Hippocampal mitochondrial dysfunction in rat aging.大鼠衰老过程中的海马体线粒体功能障碍。
Am J Physiol Regul Integr Comp Physiol. 2008 Feb;294(2):R501-9. doi: 10.1152/ajpregu.00492.2007. Epub 2007 Dec 12.
8
"Machiavellianism" and frontal dysfunction: evidence from Parkinson's disease.
Cogn Neuropsychiatry. 2007 Jul;12(4):285-300. doi: 10.1080/13546800701202316.
9
Pesticides and impairment of mitochondrial function in relation with the parkinsonian syndrome.农药与帕金森综合征相关的线粒体功能损害
Front Biosci. 2007 Jan 1;12:1079-93. doi: 10.2741/2128.
10
The role of mitochondria in inherited neurodegenerative diseases.线粒体在遗传性神经退行性疾病中的作用。
J Neurochem. 2006 Jun;97(6):1659-75. doi: 10.1111/j.1471-4159.2006.03990.x.